Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc.

NEXT STORY
American College of Rheumatology/Arthritis Foundation Release Updated Treatment Guideline for Osteoarthritis
PREV STORY
Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Silicon Valley TMS Now Offering Cutting Edge Mental Health Technology for Obsessive-Compulsive Disorder (OCD) in Northern California

author_avatar
NASDAQ Market News

Novartis to present first of its kind evidence for Cosentyx® on potential to maintain mobility in patients with AS and PsA

Long-term 4-year data in ankylosing spondylitis (AS) and 24-weeks data in psoriatic arthritis (PsA) ...

author_avatar
NASDAQ Market News

Clinical Document World Brings Thought Leaders, Innovative Approach to TMF, Inspection Readiness, Document Management, and Clinical Professionals

author_avatar
NASDAQ Market News